An MD’s Roundup of New Data on Medications for HIV Presented at CROI 2016
Some treatment failures occur most often due to the need for a high level of adherence to daily medication.
CROI 2016
Option B+ Maintained Low HIV Mother-to-Child Transmission Rates
In 2011, Malawi implemented Option B+, which provided lifelong antiretroviral therapy for all HIV-positive women who were pregnant or breastfeeding regardless of CD4 count.
Quick ART Initiation Linked With Reduction in HIV Deaths
Projections for 2025 suggest that HIV-positive patients who initiate care but never begin antiretroviral therapy could account for as many as 9% to 22% of HIV-related deaths in Rwanda, Malawi, Kenya and South Africa.
Engaging Men in HIV Clinical Trials: What Are the Challenges?
Should the focus shift to how best to reach men in trials?
Two Investigational Vaccines Show Promise for Ebola Virus Disease
Two vaccine candidates are well-tolerated and immunogenic in adult volunteers.
Innovations in HIV Care Needed to Achieve 90-90-90
The most recent estimates from UNAIDS estimates suggest that 15.8 million people are being treated with antiretroviral therapy.
Lifetime Risk for HIV Varies Significantly With Race, Gender, State
Estimates suggest about half of black men who have sex with men in the United States will be diagnosed with the virus in their lifetime, according to a study presented at CROI 2016.
Rise in Hepatitis C Noted Before 2015 HIV Outbreak in Indiana
There had been less than five HIV patients annually reported with HIV in the county, but since the start of the outbreak in late 2014, 188 people have now been diagnosed with the virus in that area.
Life Expectancy Growing For Those With HIV, But Work Remains
The disparity between infected and non-infected individuals was larger in earlier data, with researchers reporting that between 1996-2006 this gap was 26.3 years. From 2007-2011 it decreased to 13.8 years.
CDC Data Show Gains in Viral Suppression Among People With HIV
A recent study discussed at CROI 2016 Boston shows an increase in adult HIV patients who are virally suppressed, with gains in young adults and non-Hispanic black populations.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in CROI 2016
